3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics




Join our Mailing List



Syndicate

You are here : 3-RX.com > Home

Welcome to 3-RX.com, a medical and health consumer information resource containing comprehensive and unbiased information in patient-friendly language from trusted sources on over 2,500 health topics, 85 focussed health centers, and more than 18,000 drugs and medications.

Germline TP53 mutations in patients with early-onset colorectal cancer

Mar 12, 15
Germline TP53 mutations in patients with early-onset colorectal cancer

In a group of patients diagnosed with colorectal cancer at 40 or younger, 1.3 percent of the patients carried germline TP53 gene mutations, although none of the patients met the clinical criteria for an inherited cancer syndrome associated with higher lifetime risks of multiple cancers, according to a study published online by JAMA Oncology.

Li-Fraumeni syndrome is an inherited cancer syndrome usually characterized by germline TP53 mutations in which patients can develop early-onset cancers and have an increased risk for a wide array of other cancers including colorectal. The gene’s contribution to hereditary and early-onset colorectal cancer is needed for clinicians to counsel patients undergoing TP53 testing as part of a multigene risk assessment, according to the study background.

Sapna Syngal, M.D., M.P.H., of the Dana-Farber Cancer Institute, Boston, and coauthors estimated the proportion of patients with early-onset colorectal cancer who carry germline TP53 mutations. Participants were recruited from the Colon Cancer Family Registry from 1998 through 2007 and were those individuals who were diagnosed with colorectal cancer at 40 or younger and lacked a known hereditary cancer syndrome.

Among 457 eligible patients, six (1.3 percent) of them carried germline missense TP53 alterations and none of the patients met the clinical criteria for Li-Fraumeni syndrome, according to the results.

- Full Story - »»»    



  Repairing the cerebral cortex: It can be done
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  Two-step treatment improved function and decreased pain severity in veterans
  Online health information - keep it simple!
  Quitting smoking has favorable metabolic effects
  Garlic extract could help cystic fibrosis patients fight infection
  Your privacy online: Health information at serious risk of abuse
  UW research shows sensor technology may help improve accuracy of clinical breast exams
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  Drug improves measures of genetic disease that affects liver, spleen
  HPV vaccination not associated with increase in sexually transmitted infections
  Study identifies 8 signs associated with impending death in cancer patients

 
Medical Encyclopedia
Health Centers
Drugs & Medications
 

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>
Take a interactive Quiz:
I have a decreased need for sleep.
yes
no









Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site